Dual GIP and GLP-1 receptor agonist Tirzepatide improves Beta-cell function and insulin sensitivity in type 2 diabetes
Get personalized guidance and alternative treatments tailored to your needs, with expert insights backed by data and delivered with care
How PlexusDx Supports a More Personalized Approach PlexusDx emphasizes the role of genetic context in GLP-1 personalization
The maximum recommended concentration for use is 0.1%-0.6%
Ill walk through what they offer, my experience going through their process, and whether theyre worth trying
In PNA mice, GLP1/E therapy caused upregulation of pathways involved in the metabolism of non-coding RNA, estrogen-dependent gene expression, autophagy, vesicle-mediated transport, and signaling by nuclear receptors, whereas proteins related to inflammation (ROS and RNS production in phagocytes), cellular response to starvation, signaling by insulin receptor, apoptosis, and immune system were downregulated